Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ? - Wikidata - wikimedia - TriplyDB

Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?

Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?

http://www.wikidata.org/entity/Q36395910

about

How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis?

P2860

Q36902060-8C2FAF35-0F76-4B0B-9972-71D33AADFC98

P2860

Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?

http://www.wikidata.org/entity/Q36395910

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?

@ast

Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?

@en

type

label

Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?

@ast

Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?

@en

prefLabel

Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?

@ast

Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?

@en

P1433

Q36395910-2437C826-D9C9-4A73-9FD1-40B05F5FDC64

P1476

Q36395910-AF589050-35A5-4501-9A9C-18C26597ED8A

P2093

Q36395910-174776F3-C36B-49B0-9F2B-6A14EA3031D4

Q36395910-1E449576-F784-44E1-8FAD-B3E205A78A6E

Q36395910-58825771-3111-4723-B5E0-B80E9089A643

Q36395910-5F1D9FFD-FF57-4AEB-B690-A63045662311

Q36395910-7923258C-ECBD-4590-B85F-465EF626F916

Q36395910-9B149544-0CB2-4D56-B9A5-38CB18FCB6D3

Q36395910-D6B5F79B-F573-436E-9F18-B2B0D6DE9EDD

P2860

Q36395910-24C7581B-258B-436B-BCFA-EFB2A9B663F6

Q36395910-327243B4-ECBE-480F-AA72-1379695EDB02

Q36395910-4DACDB3F-2F36-4E6B-A7B0-0C3F75931993

Q36395910-563FE411-CE92-4139-897B-1A58946530D2

Q36395910-5F450C2A-9A61-4688-AECC-4DAE39D71372

Q36395910-66C2F45B-E393-4C96-80FF-85052DA257CB

Q36395910-6D9C8C58-6027-4B9D-BE04-2D41FA04FC43

Q36395910-7A3FA89E-37BB-4550-B883-A56DD435017B

Q36395910-88882AF8-162F-4374-A25B-9993D847C2F8

Q36395910-BA54DAF7-1420-46CE-B2BE-BBA73588BECB

P304

Q36395910-5FEFBDD1-B4A5-4630-A057-0C87DBF68552

P31

Q36395910-EF46D3DB-545A-4149-A222-4EABE2C2AAA1

P356

Q36395910-F113ABE6-0BFA-4FD6-A126-3A5DD86880DA

P433

Q36395910-CED247AF-5DE4-4ED9-84C4-AC9F5527FEFB

P478

Q36395910-31DF1140-8E72-4064-89DD-D04AD2218493

P50

Q36395910-C2802FC0-A28F-4281-A47D-68FDEE744C1C

P577

Q36395910-5A106EA7-9C0D-4A47-9903-C21C811645E3

P698

Q36395910-98835391-4259-47C4-8BF7-01E24E94B12D

P921

Q36395910-FD2AB66B-93B5-4759-9A21-40E455ECCD27

P932

Q36395910-B37DCB1C-4EFA-4478-B1D6-15B77E2443C7

P356

J.CLINIMAG.2015.07.026

P1433

Clinical Imaging

P1476

Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?

@en

P2093

Brian N Dontchos

http://www.w3.org/2001/XMLSchema#string

Constance D Lehman

http://www.w3.org/2001/XMLSchema#string

Diana L Lam

http://www.w3.org/2001/XMLSchema#string

Mara H Rendi

http://www.w3.org/2001/XMLSchema#string

Nicole K Andeen

http://www.w3.org/2001/XMLSchema#string

Sana Parsian

http://www.w3.org/2001/XMLSchema#string

Savannah C Partridge

http://www.w3.org/2001/XMLSchema#string

P2860

Intravenous administration of Gd-DTPA prior to DWI does not affect the apparent diffusion constant.

High-resolution diffusion-weighted imaging for the separation of benign from malignant BI-RADS 4/5 lesions found on breast MRI at 3T

Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging.

Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.

In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.

Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade.

Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis?

National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009.

Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: a pilot study.

A prognostic index for ductal carcinoma in situ of the breast.

P304

125-129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CLINIMAG.2015.07.026

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26365872

http://www.w3.org/2001/XMLSchema#string

P921

P932

4688163

http://www.w3.org/2001/XMLSchema#string